Prosecution Insights
Last updated: April 19, 2026
Application No. 18/482,256

SYSTEMS AND METHODS FOR MANAGED TRAINING AND REHABILITATION VIA ELECTRICAL STIMULATION

Non-Final OA §102§103
Filed
Oct 06, 2023
Examiner
EDWARDS, PHILIP CHARLES
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Neuro20 Technologies Corp.
OA Round
1 (Non-Final)
86%
Grant Probability
Favorable
1-2
OA Rounds
2y 7m
To Grant
99%
With Interview

Examiner Intelligence

Grants 86% — above average
86%
Career Allow Rate
453 granted / 529 resolved
+15.6% vs TC avg
Moderate +14% lift
Without
With
+14.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
39 currently pending
Career history
568
Total Applications
across all art units

Statute-Specific Performance

§101
4.7%
-35.3% vs TC avg
§103
49.2%
+9.2% vs TC avg
§102
31.5%
-8.5% vs TC avg
§112
10.9%
-29.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 529 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 2-19 in the reply filed on 2/23/2026 is acknowledged. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 2-3, 6, and 8-19 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Matsuura et al. (Pub. No.: US 2018/0093121 A1); hereinafter referred to as “Matsuura”. Regarding claim 2, Matsuura discloses an electrical stimulation training and rehabilitation system (e.g. see [0041]) comprising: a machine-washable textile garment (e.g. see [0030], [0046]), comprising: a plurality of conductive electrodes positioned along the textile garment at various locations so as to facilitate neuromuscular stimulation of various regions of a body of a wearer (e.g. see [0034]-[0037]); and at least one integrated sensor (e.g. see [0024]) adapted to collect biodata indicative of a physiological parameter of the wearer; and a controller (e.g. see figure 1, element 14, [0023]) configured to provide adjustable stimulation signals (e.g. see [0023], [0027]. Note: [0027] discloses “Effectors may also apply an electrical current to the dermal surface, such as to produce an electrical shock or muscular stimulation”) to the plurality of conductive electrodes and to receive the biodata, wherein the controller is configured to generate and/or adjust the stimulation signals (e.g. see [0023]-[0027]) to cause coordinated movement of the wearer for neuromuscular rehabilitation (e.g. see [0041]). Regarding claim 3, Matsuura discloses the at least one integrated sensor includes at least one of a temperature sensor (e.g. see [0024]), a wetness sensor (e.g. see [0024]), or a cardiac sensor (e.g. see [0024]). Regarding claims 6 and 16, Matsuura discloses the plurality of conductive electrodes are configured to contact at least body locations corresponding to muscles of the arms ([0069]), chest ([0068]), and back ([0068]) when the garment is worn (e.g. see fig. 2, [0029], [0034], [0037]). Regarding claim 8, Matsuura discloses the controller is removably connected to a signal pathway with a connector port, the signal pathway connecting the plurality of conductive electrodes and the controller (e.g. see [0059], [0116]-[0118]. Note: [0059] states “a controller 106 may be coupled with sensors 104A-104C via a network of flexible signal conductors 108 (which may be electrically conductive or optical). In one embodiment, sensors 104A-104C may communicate with controller 106 via a wired (e.g., hard wired) interface”). Regarding claim 9, Matsuura discloses the connector port (e.g. see figure 3 elements 302, 306) comprises: an outer printed circuit (e.g. see figure 3 element 306, [0049], “flexible printed circuitry (FPC)”) on an outside (e.g. see [0044], [0049]) of the garment for connecting to the controller, an inner printed circuit (e.g. see figure 3 element 306, [0049], “flexible printed circuitry (FPC)”) on an inside (e.g. see [0044], [0049]) of the garment connected to the signal pathway, and flexible wires (e.g. see figure 3 element 306, [0045], [0049]) connecting the outer circuit to the inner circuit (Note: Any of the conductive circuit between the electrodes and the controller may be interpreted as a “signal pathway” or “connector”. Also, any of the printed circuitry will read on “wire”). Regarding claim 10, Matsuura discloses the connector port (e.g. see figure 3 elements 302, 306) comprises a first connector port (e.g. see figure 3 elements 302, 306) on a first side (e.g. see [0044], [0049]) of the garment and a second connector port (e.g. see figure 3 elements 302, 306) on a second side (e.g. see [0044], [0049]) of the garment; and the controller (e.g. see [0116]-[0118]) is removably connectable to both the first connector port and second connector port (Note: Any of the conductive circuit between the electrodes and the controller may be interpreted as a “port” or “connector”). Regarding claim 11, Matsuura discloses the controller is configured to send the biodata to a user computing device to facilitate monitoring of the physiological parameter (e.g. see figure 1 elements 18 and 20, figure 2 elements 112, 120, 198, 199). Regarding claim 12, see claims 2 and 3 above. Regarding claim 13, Matsuura discloses a manager device (e.g. see figure 2 element 112) configured to allow a user to adjust a parameter of the stimulation signals (e.g. see [0061]). Regarding claim 14, Matsuura discloses the stimulation signals comprise a pre-set pattern configured to cause a coordinated motion of a person wearing the garment (e.g. see [0067], [0076]-[0077]). Regarding claim 15, Matsuura discloses the coordinated motion is configured for neuromuscular rehabilitation (e.g. see [0041]). Regarding claim 17, Matsuura discloses the controller is configured to automatically adjust the stimulation signals according to the biodata (e.g. see [0023]-[0027]). Regarding claim 18, Matsuura discloses at least one of the plurality of conductive electrodes or the sensor is connected to the controller via a signal pathway integrated in the garment (e.g. see figure 1 elements 12, 14, and 16, [0023]). Regarding claim 19, Matsuura discloses the controller is releasably connected to the garment (e.g. see figure 11 element 550, [0116]. Note: [0116] states “The electronics component chamber 520 may alternatively or additionally be carried in a separate removable, interchangeable electronically enabled module 550 as illustrated in FIG. 11)). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 4 is/are rejected under 35 U.S.C. 103 as being unpatentable over Matsuura in view of Girouard et al. (Pub. No.: US 2016/0303363 A1); hereinafter referred to as “Girouard”. Regarding claim 4, Matsuura discloses in [0034] and [0043] that the number of electrodes may vary but is silent as to the plurality of conductive electrodes comprises at least 20 electrodes. Girouard teaches it is known to use such a modification as set forth in [0235]-[0238] to provide more complete coverage of the anatomy being sensed and stimulated. It would have been obvious to one having ordinary skill in the art at the time the invention was filed to use at least 20 electrodes as taught by Girouard in the system of Matsuura, since said modification would provide the predictable results of more complete coverage of the anatomy being sensed and stimulated. Claim(s) 5 and 7, is/are rejected under 35 U.S.C. 103 as being unpatentable over Matsuura in view of Yoo et al. (Pub. No.: US 2019/0001135 A1); hereinafter referred to as “Yoo”. Regarding claim 5, Matsuura discloses the invention but is silent as to the plurality of conductive electrodes comprise dry electrodes. Yoo teaches that it is known to use such a modification as set forth in [0204] and [0215] to provide electrodes that are well known in the art (e.g. see [0215]). It would have been obvious to one having ordinary skill in the art at the time the invention was made to use dry electrodes as taught by Yoo in the system of Matsuura, since said modification would provide the predictable results of electrodes that are well known in the art. Regarding claim 7, Matsuura discloses the invention but is silent as to the plurality of conductive electrodes include an anti-microbial agent. Yoo teaches that it is known to use such a modification as set forth in [0215] to deter odor (microfiber nylon, or nylon/lycra blend) and/or maintain cleanliness (e.g. see [0215]). It would have been obvious to one having ordinary skill in the art at the time the invention was made to use an anti-microbial agent as taught by Yoo in the system of Matsuura, since said modification would provide the predictable results of detering odor (microfiber nylon, or nylon/lycra blend) and/or maintaining cleanliness. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PHILIP C EDWARDS whose telephone number is (571)270-1804. The examiner can normally be reached Mon-Fri, 9:00-5:00 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Unsu Jung can be reached at 571-272-8506. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /P.C.E/Examiner, Art Unit 3792 /UNSU JUNG/Supervisory Patent Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Oct 06, 2023
Application Filed
Mar 20, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12569678
MULTI-ELECTRODE MINIATURE ELECTRICAL STIMULATION SYSTEM AND TREMOR RELIEF WRISTBAND
2y 5m to grant Granted Mar 10, 2026
Patent 12521029
SYSTEM AND METHOD FOR MULTIPLEXING AN OPTICAL SENSOR
2y 5m to grant Granted Jan 13, 2026
Patent 12515062
METHOD AND APPARATUS FOR DELIVERING ANTI-TACHYCARDIA PACING
2y 5m to grant Granted Jan 06, 2026
Patent 12478786
ELECTRODE DEVICES AND METHODS FOR NEUROSTIMULATION TREATMENT
2y 5m to grant Granted Nov 25, 2025
Patent 12447341
EVOKED RESPONSE-BASED SYSTEMS AND METHODS FOR DETERMINING ELECTRODE POSITIONING WITHIN A COCHLEA
2y 5m to grant Granted Oct 21, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
86%
Grant Probability
99%
With Interview (+14.4%)
2y 7m
Median Time to Grant
Low
PTA Risk
Based on 529 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month